Crescent Biopharma grants employee stock options for 19,425 shares at $14.47 each

• Crescent Biopharma adopted inducement equity awards granting options for 19,425 ordinary shares to one non-executive employee under its 2025 plan.
• Options carry a 10-year term with a USD 14.47 exercise price, set at the July 31 Nasdaq closing price.
• Vesting schedule: 25% on the first anniversary of the employee’s start date, then monthly vesting of the remainder in 48 installments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.